These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 36803019)
21. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Raj G; Kumar R; McKinney WP Arch Intern Med; 1999 Dec 13-27; 159(22):2721-4. PubMed ID: 10597763 [TBL] [Abstract][Full Text] [Related]
22. INR Response to Low-Dose Vitamin K in Warfarin Patients. Kulig CE; Roberts AJ; Rowe AS; Kim H; Dager WE Ann Pharmacother; 2021 Oct; 55(10):1223-1229. PubMed ID: 33543639 [TBL] [Abstract][Full Text] [Related]
23. Effectiveness and safety of a management protocol to correct over-anticoagulation with oral vitamin K: a retrospective study of 1,043 cases. Denas G; Marzot F; Offelli P; Stendardo A; Cucchini U; Russo R; Nante G; Iliceto S; Pengo V J Thromb Thrombolysis; 2009 Apr; 27(3):340-7. PubMed ID: 18338109 [TBL] [Abstract][Full Text] [Related]
24. Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial. Crowther MA; Ageno W; Garcia D; Wang L; Witt DM; Clark NP; Blostein MD; Kahn SR; Vesely SK; Schulman S; Kovacs MJ; Rodger MA; Wells P; Anderson D; Ginsberg J; Selby R; Siragusa S; Silingardi M; Dowd MB; Kearon C Ann Intern Med; 2009 Mar; 150(5):293-300. PubMed ID: 19258557 [TBL] [Abstract][Full Text] [Related]
25. Effect of vitamin K administration on rate of warfarin reversal. Polito NB; Kanouse E; Jones CMC; McCann M; Refaai MA; Acquisto NM Transfusion; 2019 Apr; 59(4):1202-1208. PubMed ID: 30714620 [TBL] [Abstract][Full Text] [Related]
26. Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin. Woods K; Douketis JD; Kathirgamanathan K; Yi Q; Crowther MA J Thromb Thrombolysis; 2007 Oct; 24(2):93-7. PubMed ID: 17380255 [TBL] [Abstract][Full Text] [Related]
27. Effect of Intravenous Versus Subcutaneous Phytonadione on Length of Stay for Patients in Need of Urgent Warfarin Reversal. Mottice BL; Soric MM; Legros E Am J Ther; 2016; 23(2):e345-9. PubMed ID: 25461960 [TBL] [Abstract][Full Text] [Related]
28. Vitamin K versus warfarin interruption alone in patients without bleeding and an international normalized ratio > 10. Farrow GS; Delate T; McNeil K; Jones AE; Witt DM; Crowther MA; Clark NP J Thromb Haemost; 2020 May; 18(5):1133-1140. PubMed ID: 32073738 [TBL] [Abstract][Full Text] [Related]
29. Management of Supratherapeutic International Normalized Ratio without Bleeding after Warfarin Use: An Evaluation of Vitamin K Administration (SUPRA-WAR-K Study). Tai C; Wu H; San C; Chua D Can J Hosp Pharm; 2017; 70(3):207-214. PubMed ID: 28680174 [TBL] [Abstract][Full Text] [Related]
30. Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage. Rhoney DH; La M; Merz M; Cook A; Owusu KA; Roels C; Blunck J; Shewmaker J; Sangha KS; Farrokh S; Lewin J; Chester KW; Human T; Bledsoe K; Greene K; Levesque M; Rocker JC; Davis G; Neyens R; Lassiter TF; Adriance SM Neurocrit Care; 2021 Aug; 35(1):130-138. PubMed ID: 33219462 [TBL] [Abstract][Full Text] [Related]
32. A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin. Watson HG; Baglin T; Laidlaw SL; Makris M; Preston FE Br J Haematol; 2001 Oct; 115(1):145-9. PubMed ID: 11722425 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of intravenous phytonadione (vitamin K1) in patients on long-term oral anticoagulant therapy. Shields RC; McBane RD; Kuiper JD; Li H; Heit JA Mayo Clin Proc; 2001 Mar; 76(3):260-6. PubMed ID: 11243272 [TBL] [Abstract][Full Text] [Related]
34. Appraisal of current vitamin K dosing algorithms for the reversal of over-anticoagulation with warfarin: the need for a more tailored dosing regimen. Sconce EA; Kamali F Eur J Haematol; 2006 Dec; 77(6):457-62. PubMed ID: 17042764 [TBL] [Abstract][Full Text] [Related]
35. A retrospective evaluation of vitamin K1 therapy to reverse the anticoagulant effect of warfarin. Fan J; Armitstead JA; Adams AG; Davis GA Pharmacotherapy; 2003 Oct; 23(10):1245-50. PubMed ID: 14594342 [TBL] [Abstract][Full Text] [Related]
36. Fixed- versus variable-dose prothrombin complex concentrate protocol for vitamin K antagonist reversal. Bizzell AC; Mousavi MK; Yin E Int J Hematol; 2021 Sep; 114(3):334-341. PubMed ID: 34191234 [TBL] [Abstract][Full Text] [Related]
37. Low-dose oral vitamin K therapy for the management of asymptomatic patients with elevated international normalized ratios: a brief review. Wilson SE; Watson HG; Crowther MA CMAJ; 2004 Mar; 170(5):821-4. PubMed ID: 14993179 [TBL] [Abstract][Full Text] [Related]
39. Correction of international normalised ratio in major bleeding related to vitamin K antagonists is associated with better survival: A UK study. Tan J; MacCallum P; Curry N; Stanworth S; Tait C; Morris JK; Green L Thromb Res; 2021 Jan; 197():153-159. PubMed ID: 33220564 [TBL] [Abstract][Full Text] [Related]
40. The effect of preoperative vitamin K on the INR in bridging therapy. Bayewitz A; Scorziello B; Maala C; Giannattasio E; Billett HH Int J Hematol; 2015 Mar; 101(3):264-7. PubMed ID: 25637256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]